Individual timelines may vary depending on initial B12 levels and overall health
The right option depends on your goals, health history, lab work, medications, and provider guidance
Vitamin B12 injections increase blood cell production including white blood cells
In a notable phase II clinical trial published in The Lancet (2008), Tesofensine demonstrated dose-dependent weight loss of up to 10.6% over 24 weeks in obese individualssubstantially higher than placebo or many existing weight-loss drugs
Prescribing decisions should involve a physician experienced in peptide therapy, baseline lab work (fasting glucose, insulin, IGF-1, CBC, CMP), and scheduled follow-up labs at 6 to 8 weeks